Ceyda Anar

Ceyda Anar

Auto-generated profile, based on publicly available information

Ceyda Anar

Department of Chest Diseases, Izmir Katip Çelebi University Atatürk Training and Resource Hospital, Basın Sitesi, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Endoscopic Ultrasound
Verified
Journal Article
Open access
CACeyda Anar
Ceyda Anar
OEOnurFevzi Erer
OnurFevzi Erer
SESerhat Erol
Serhat Erol
ZAZekiye Aydoğdu
Zekiye Aydoğdu
SÖSerirAktoğu Özkan
SerirAktoğu Özkan
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), which enables cytological examination of mediastinal lymph node (LN) aspiration samples, is a safe and minimally invasive method for diagnosis and staging of lung cancer and diagnosis of diseases affecting mediastinal LNs. In this study, we investigated the yield of EBUS-TBNA for diagnosis of lymphoma and reviewed the literature since the British Thoracic Society (BTS) guidelines were published. We retrospectively evaluated our database for patients who underwent EBUS between March 2011 and December 2014. One hundred eighty-nine patients with isolated mediastinal lymphadenopathy were included in the study. Patients with other causes of lymphadenopathy, such as lung cancer or extrathoracic malignancy, and those with pulmonary lesions accompanying mediastinal lymphadenopathy were excluded from the study. Patients with final diagnosed lymphoma were included in the study on the basis of a history of lymphoma or newly evaluated mediastinal lymphadenopathy. The sensitivity and negative predictive value (NPV) of EBUS-TBNA were calculated. There were 13 patients with the final diagnosis of lymphoma. Eleven of them were new diagnoses and 2 patients were known chronic lymphocytic leukemia (CLL), and underwent EBUS-TBNA for determination of recurrence. Twelve EBUS-TBNA procedures were performed for suspected new cases. Three (25%) were diagnostic, 2 (16.7%) were suspicious for lymphoma and underwent further interventions for definite diagnosis, and 7 (58.3%) were false negative. All 3 patients diagnosed with EBUS-TBNA were non-Hodgkin lymphoma (NHL). None of the Hodgkin lymphoma (HL) cases could be diagnosed with EBUS-TBNA. The overall diagnostic sensitivity and NPV of EBUS-TBNA in detecting lymphoma was 65% and 96.1%, respectively. For the newly diagnosed lymphoma cases, EBUS-TBNA had a sensitivity of 61.1%. In conclusion, we believe that since the publication of the BTS guidelines, the value of EBUS-TBNA in the diagnosis of lymphoma still remains controversial. EBUS-TBNA can be the first diagnostic modality in diagnosis of recurrent lymphomas. However, for suspected new cases, especially for HL, the diagnostic yield of EBUS-TBNA is low and negative results do not exclude lymphoma. Further interventions such as mediastinoscopy should be performed for high-suspicion patients.

16 June 2014 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
TITuba İnAl
Tuba İnAl
CACeyda Anar
Ceyda Anar
GPGülru Polat
Gülru Polat
IÜİpEk Ünsal
İpEk Ünsal
HHHüseyin Halilçolar
Hüseyin Halilçolar

6 January 2018 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
CACeyda Anar
Ceyda Anar
MYMelike Yüksel Yavuz
Melike Yüksel Yavuz
FGFiliz Güldaval
Filiz Güldaval
YVYelda Varol
Yelda Varol
DKDilek Kalenci
Dilek Kalenci
The aim of this paper was to evaluate the availability of FRAX for assessing osteoporosis risk, and to demonstrate the importance of vitamin D levels in COPD patients. Fourty-six males who fulfilled the COPD diagnostic criteria defined by GOLD were included. Age, race, BMI, physical activity frequency, smoking and dietary habits, age at COPD diagnosis, disease duration, fractures history, and medications use were determined. Levels of 25(OH)D were detected. BMD was measured by DXA at lumbar spine, femoral neck, and entire femur, and classified according to ISCD. FRAX score was calculated. Control group was composed of 40 non-smoker individuals without previous history of pulmonary diseases. 25(OH)D levels were significantly different between patients and controls. In the COPD group, a statistically significant difference in vitamin D levels was detected among the A, B, C, and D grades, while no such significant differences in FRAX scores were detected. 25(OH)D levels were significantly low in COPD patients with disease exacerbations and hospitalizations in the previous one year. No correlation was detected between vitamin D levels and the FRAX score. A positive correlation was observed between vitamin D levels and T-score. FRAX scores were higher and vitamin D levels were lower in osteoporotic COPD patients than in non-osteoporotic COPD patients. Using FRAX for assessing osteoporosis in COPD can reduce fracture risk and allow adequate treatment. Since vitamin D levels are related to exacerbations and hospitalizations, vitamin D supplementation may be needed in COPD patients, especially in those with high FRAX scores.

12 February 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
MBMelih Buyuksirin
Melih Buyuksirin
CACeyda Anar
Ceyda Anar
GEGülru Erbay
Gülru Erbay
GKGülistan Karadeniz
Gülistan Karadeniz
Pulmonary embolism,C-reactive protein,mortality

1 January 2017 in Endoscopic Ultrasound
Verified
Journal Article
Open access
PDF file
CACeyda Anar
Ceyda Anar
OEOnur Fevzi Erer
Onur Fevzi Erer
SESerhat Erol
Serhat Erol
ZAZekiye Aydoğdu
Zekiye Aydoğdu
SÖSerir Aktoğu Özkan
Serir Aktoğu Özkan
Aim: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a safe and minimally invasive procedure that can be performed in outpatient settings. Several studies have demonstrated the usefulness of EBUS-TBNA in the diagnosis of sarcoidosis and malignant diseases. This study focused on the role of cell block (CB) analysis in determining the diagnostic yield of EBUS-TBNA in malignant diseases and sarcoidosis. Materials and Methods: The study was conducted at a training and research hospital. Records of patients who underwent EBUS-TBNA between March 2011 and December 2014 for diagnosed sarcoidosis or malignancy were retrospectively analyzed. Results of all EBUS-TBNA smears and CB were separately evaluated to determine the diagnostic value of each. Results: There were 84 sarcoidosis and 179 malignancy patients. In the malignancy group, CB contributed to cancer diagnosis in 15 (8.3%) patients and subclassification in 19 (10.6%) patients. In the sarcoidosis group, for 45.2% of patients (38/84), smears were not diagnostic but CB showed granulomatous inflammation. Conclusion: CB significantly increases the diagnostic yield of EBUS-TBNA for sarcoidosis. In our study, in the malignancy group the diagnostic yield was low but it was helpful for subclassification, especially for adenocarcinoma.

14 July 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
FGFiliz Guldaval
Filiz Guldaval
GEGülru Erbay
Gülru Erbay
SDSibel Doruk
Sibel Doruk
GKGulistan Karadeniz
Gulistan Karadeniz
AAAYSU AYRANCI
AYSU AYRANCI
CACeyda Anar
Ceyda Anar
Chronic obstructive pulmonary disease,smoker,non-smoker